draize human repeat insult patch test (ript) (Bristol Myers)
90
Structured Review
Bristol Myers
draize human repeat insult patch test (ript)
Draize Human Repeat Insult Patch Test (Ript), supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/draize+human+repeat+insult+patch+test+(ript)/draize+human+repeat+insult+patch+test++ript+/pm33605820-10-14-6
Average 90 stars, based on 1 article reviews
Draize Human Repeat Insult Patch Test (Ript), supplied by Bristol Myers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/draize+human+repeat+insult+patch+test+(ript)/draize+human+repeat+insult+patch+test++ript+/pm33605820-10-14-6
Average 90 stars, based on 1 article reviews
draize human repeat insult patch test (ript) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Derivative Assay:Article Title: The 21-day cumulative irritation assay in man: a half-century summary and re-evaluation. Article Snippet: The 21-day cumulative irritation test (21-day CIT) has been widely used in dermatopharmacology and dermatotoxicology to assess the irritation potential of topical products.. Since described by Lanman in 1968, it has been modified, shortened, re-evaluated, and statistically analysed by multiple groups of authors.. As the assay has been recommended in FDA draft guidance, we bring subsequent experience to date. Produced:Article Title: The 21-day cumulative irritation assay in man: a half-century summary and re-evaluation. Article Snippet: The 21-day cumulative irritation test (21-day CIT) has been widely used in dermatopharmacology and dermatotoxicology to assess the irritation potential of topical products.. Since described by Lanman in 1968, it has been modified, shortened, re-evaluated, and statistically analysed by multiple groups of authors.. As the assay has been recommended in FDA draft guidance, we bring subsequent experience to date. |